Skip to main content

Table 4 Number of palivizumab doses dispensed by RSV season and eligibility criteria

From: RSV prophylaxis use in high-risk infants in Western Australia, 2002-2013: a record linkage cohort study

  Criterion 1 N = 457 Criterion 2 N = 68 Criterion 3 N = 227 Other N = 50 Total N = 744
n (%) n (%) n (%) n (%) n (%)
First RSV season 366 (80.1) 57 (83.8) 150 (66.1) 36 (72.0) 562 (75.5)
Second RSV season 75 (16.4) < 10 (< 14.7) 70 (30.8) < 5 (< 10.0) 147 (19.8)
Third RSV season 16 (3.5) < 5 (< 7.4) 7 (3.1) < 15 (< 30.0) 35 (4.7)
  1. *NOTE: (1) Cell sizes of less than 5 have been suppressed
  2. (2) Criterion 1: gestational age < 28 weeks and CLD; criterion 2: gestational age < 28 weeks and identified as Aboriginal; criterion 3: CHD but not in criterion 1 or criterion 2 group